DaVita Inc. (NYSE:DVA) Given Consensus Rating of "Hold" by Brokerages

Shares of DaVita Inc. (NYSE:DVA - Get Free Report) have received a consensus rating of "Hold" from the six analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $166.33.

Several research analysts recently issued reports on DVA shares. Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. StockNews.com raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. Finally, Cowen reiterated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th.

DaVita Stock Performance

Shares of DaVita stock opened at $140.91 on Friday. The company has a 50 day moving average of $146.04 and a 200-day moving average of $154.53. The company has a market cap of $11.27 billion, a PE ratio of 13.12, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita has a 1-year low of $131.44 and a 1-year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities research analysts forecast that DaVita will post 10.76 earnings per share for the current fiscal year.

Institutional Trading of DaVita

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DVA. UMB Bank n.a. raised its position in shares of DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares during the period. Copia Wealth Management bought a new position in shares of DaVita in the fourth quarter valued at $30,000. SBI Securities Co. Ltd. acquired a new position in shares of DaVita during the fourth quarter valued at about $41,000. Coppell Advisory Solutions LLC increased its position in shares of DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after acquiring an additional 100 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan bought a new position in DaVita in the 4th quarter valued at about $55,000. 90.12% of the stock is owned by institutional investors.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.